Should We Measure C-reactive Protein on Earth or Just on JUPITER?

被引:17
作者
Bajpai, Ambareesh [1 ]
Goyal, Abhinav [1 ]
Sperling, Laurence [1 ]
机构
[1] Emory Univ, Dept Cardiol, Atlanta, GA 30322 USA
关键词
CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK PREDICTION; MIDDLE-AGED MEN; FIBRIN D-DIMER; INFLAMMATORY MARKERS; RANDOMIZED-TRIAL; STATIN THERAPY; WOMEN; MORTALITY; INTERLEUKIN-6;
D O I
10.1002/clc.20681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence for the role of inflammation in the pathogenesis of atherosclerosis is compelling and has generated interest in high-sensitivity C-reactive protein (hs-CRP) as a marker of cardiovascular risk. Data regarding hs-CRP and cardiovascular risk, though largely consistent, is of unclear clinical relevance. Most recently, the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has led to further debate regarding the utility of hs-CRP. This article provides a comprehensive review of the data regarding cardiovascular risk and hs-CRP with an emphasis on the JUPITER trial and concludes with an evidence-based analysis of the current role of hs-CRP in cardiovascular risk assessment.
引用
收藏
页码:190 / 198
页数:9
相关论文
共 49 条
[11]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[12]   A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism [J].
Glynn, Robert J. ;
Danielson, Eleanor ;
Fonseca, Francisco A. H. ;
Genest, Jacques ;
Gotto, Antonio M., Jr. ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Libby, Peter ;
Lorenzatti, Alberto J. ;
MacFadyen, Jean G. ;
Nordestgaard, Borge G. ;
Shepherd, James ;
Willerson, James T. ;
Ridker, Paul M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1851-1861
[13]   Improving coronary heart disease risk assessment in asymptomatic people - Role of traditional risk factors and noninvasive cardiovascular tests [J].
Greenland, P ;
Smith, SC ;
Grundy, SM .
CIRCULATION, 2001, 104 (15) :1863-1867
[14]   Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly [J].
Harris, TB ;
Ferrucci, L ;
Tracy, RP ;
Corti, MC ;
Wacholder, S ;
Ettinger, WH ;
Heimovitz, H ;
Cohen, HJ ;
Wallace, R .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :506-512
[15]  
Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278
[16]   von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study [J].
Jager, A ;
van Hinsbergh, VWM ;
Kostense, PJ ;
Emeis, JJ ;
Yudkin, JS ;
Nijpels, G ;
Dekker, JM ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :3071-3078
[17]   Prevalence of conventional risk factors in. patients with coronary heart disease [J].
Khot, UN ;
Khot, MB ;
Bajzer, CT ;
Sapp, SK ;
Ohman, EM ;
Brener, SJ ;
Ellis, SG ;
Lincoff, AM ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :898-904
[18]   Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women - Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 [J].
Koenig, Wolfgang ;
Khuseyinova, Natalie ;
Baumert, Jens ;
Thorand, Barbara ;
Loewel, Hannelore ;
Chambless, Lloyd ;
Meisinger, Christa ;
Schneider, Andrea ;
Martin, Stephan ;
Kolb, Hubert ;
Herder, Christian .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (12) :2745-2751
[19]  
KUSHNER I, 1990, HOSP PRACT, V25, P13
[20]   C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men:: a population-based cohort study [J].
Laaksonen, DE ;
Niskanen, L ;
Nyyssönen, K ;
Punnonen, K ;
Tuomainen, TP ;
Salonen, JT .
EUROPEAN HEART JOURNAL, 2005, 26 (17) :1783-1789